Leslie's Inc. Files Proxy Statement Supplement

TL;DR

Leslie's filed a proxy supplement for their March 15th shareholder meeting. No fee.

AI Summary

Leslie's, Inc. filed a DEFA14A on March 7, 2024, as a supplement to its proxy statement for the annual shareholder meeting on March 15, 2024. This filing indicates no fee was required for this submission.

Why It Matters

This filing provides updated information to shareholders before their annual meeting, ensuring they have the latest details for voting on company matters.

Risk Assessment

Risk Level: low — This is a routine administrative filing related to an upcoming shareholder meeting and does not contain new financial or strategic information that would typically impact risk.

Key Players & Entities

• Leslie's, Inc. (company) — Registrant and filer of the proxy statement
• 0001193125-24-060944 (filing_id) — Accession number for the filing
• March 15, 2024 (date) — Date of the Annual Meeting of Shareholders
• March 7, 2024 (date) — Filing date of the DEFA14A

FAQ

Filing Documents

• d800234ddefa14a.htm (DEFA14A) — 17KB
• 0001193125-24-060944.txt ( ) — 18KB

From the Filing

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14A-6(E)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to Section 240.14a-12 Leslies, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. LESLIES, INC. SUPPLEMENT TO PROXY STATEMENT RELATED TO ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON MARCH 15, 2024 Leslies, Inc. (the Company) is filing these definitive additional materials, which should be read together with the Companys definitive proxy statement (the Proxy Statement) filed with the Securities and Exchange Commission on January 24, 2024 related to the Companys 2024 Annual Meeting of Shareholders (the Meeting). Except as specifically supplemented below, all other information set forth in the Proxy Statement, as amended or supplemented from time to time, remains unchanged. From and after the date of this supplement, all references to the Proxy As previously announced, the Company has experienced a number of changes to the composition of our Board of Directors (the Board) beginning in late 2023, including Mr. Steven L. Ortegas decision not to stand for re-election at the Meeting. Following the Meeting and Mr. Ortegas departure from the Board, the Company would expect, in the absence of any further action by the Board, to have a seven-member classified Board, with three Class I directors whose terms expire at the 2025 Annual Meeting of Shareholders, one Class II director whose term expires at the 2026 Annual Meeting of Shareholders (the 2026 Annual Meeting), and three Class III directors, each of whom will stand for election at the Meeting and whose terms, if re-elected, would expire at the 2027 Annual Meeting of Shareholders (the 2027 Annual Meeting). In order to make the number of directors in each of Classes I, II and III of the Board as equal as possible, the Board has determined that, effective immediately following the completion of the Meeting, Mr. Seth Estep (or any successor) will cease to be a Class III director, and his seat will be reassigned to Class II of the Board. Mr. Estep will stand for re-election as a Class III director at the Meeting, as contemplated by the Proxy Statement, and, if re-elected at the Meeting, as a result of this change, will again stand for election as a Class II director at the 2026 Annual Meeting, one year earlier than he otherwise would have stood for election had he continued as a Class III director. The Board is implementing these changes in accordance with Article VI of the Companys Sixth Amended and Restated Certificate of Incorporation (the Certificate), which provides that any increase or decrease in the size of the Board be apportioned among the Boards classes so as to maintain the number of directors in each class as nearly equal as possible until the 2027 Annual Meeting (at which time the Board will cease to be classified, consistent with the amendments to our Certificate to phase in the declassification of our Board that were approved by shareholders at the 2023 annual meeting of shareholders). The Companys slate of nominees for the Meeting is unchanged and continues to consist of the three Class III directors previously scheduled to stand for election at the Meeting: Ms. Susan OFarrell, Ms. Claire Spofford and Mr. Seth Estep. If all the nominees are re-elected, following the meeting and the corresponding effectiveness of Mr. Esteps (or any successors) reclassification, the Board will consist of seven directors, composed of three Class I directors, two Class II directors and two Class III directors, as follows: (a) Class I Directors: Ms. Yolanda Daniel, Mr. Michael R. Egeck, and Mr. Eric Kufel; (b) Class II Directors: Mr. Seth Estep and Mr. John Strain; and (c) Class III Directors: Ms. Susan OFarrell and Ms. Claire Spofford. Biographical and share ownership information with respect to the nominees standing for re-election at the Meeting, including Mr. Estep, is set forth in the Proxy Statement under the headings Proposal 1: Election of DirectorsDirector NomineesNominees for Election to a Three-Year Term Expiring at the 2027 Annual Meeting of Shareholders and Beneficial Ownership of Securities. Your Board recommends a vote FOR the election of the three Class III director nominees. If you have already voted your shares and do not wish to chan

View Full Filing

View this DEFA14A filing on SEC EDGAR